265 related articles for article (PubMed ID: 11532861)
1. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
Zhu W; Zhang JS; Young CY
Carcinogenesis; 2001 Sep; 22(9):1399-403. PubMed ID: 11532861
[TBL] [Abstract][Full Text] [Related]
2. Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
Chung BH; Lee HY; Lee JS; Young CY
Cancer Lett; 2006 May; 236(2):222-8. PubMed ID: 16029925
[TBL] [Abstract][Full Text] [Related]
3. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
[TBL] [Abstract][Full Text] [Related]
4. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.
Kollara A; Diamandis EP; Brown TJ
J Steroid Biochem Mol Biol; 2003 Apr; 84(5):493-502. PubMed ID: 12767274
[TBL] [Abstract][Full Text] [Related]
5. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY
Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
7. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
8. An androgen response element mediates LNCaP cell dependent androgen induction of the hK2 gene.
Mitchell SH; Murtha PE; Zhang S; Zhu W; Young CY
Mol Cell Endocrinol; 2000 Oct; 168(1-2):89-99. PubMed ID: 11064155
[TBL] [Abstract][Full Text] [Related]
9. Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4.
Wang MH; Abreu-Delgado Y; Young CY
Urology; 2003 Jul; 62(1):167-71. PubMed ID: 12837460
[TBL] [Abstract][Full Text] [Related]
10. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
[TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
12. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
15. Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression.
Zhang S; Hsieh ML; Zhu W; Klee GG; Tindall DJ; Young CY
Endocrinology; 1999 Apr; 140(4):1665-71. PubMed ID: 10098501
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE
Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of prostate kallikrein-like genes by androgen.
Wolf DA; Schulz P; Fittler F
Mol Endocrinol; 1992 May; 6(5):753-62. PubMed ID: 1376410
[TBL] [Abstract][Full Text] [Related]
19. Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene.
Zhang S; Murtha PE; Young CY
Biochem Biophys Res Commun; 1997 Feb; 231(3):784-8. PubMed ID: 9070893
[TBL] [Abstract][Full Text] [Related]
20. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene.
Murtha P; Tindall DJ; Young CY
Biochemistry; 1993 Jun; 32(25):6459-64. PubMed ID: 7686046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
